The long-term goal of this project is to define mechanisms of cancer invasion triggered by microenvironment cues and driven by integrins ?3?1 and ?6?4. These integrins negotiate interactions of cells with laminin-5 (Ln-5), a major component of epithelial basement membranes. Altered expression of both ?6?4 and Ln-5 is associated with cancer progression. Definition of possible causal mechanisms, though, has been challenging because both loss and acquisition of ?6?4/Ln-5 functions were reported to promote tumorigenesis. In this proposal, we plan to assess the validity of an integrated view reconciling these contrasting data.
In Aim 1, we will test the hypothesis that invading cancer cells """"""""pave their way"""""""" with autocrine-secreted extracellular matrix, particularly Ln-5. A challenge of conventional views of cancer cell migration, this hypothesis is based on the physiological switch from static adhesion to migration that occurs in remodeling or healing epithelia, and is supported by our preliminary experiments in which cancer cell scattering was inhibited by Ln-5 or ?3?1, but not ?6 antibodies. To test this hypothesis, we will determine whether secreted Ln-5 is essential for cell scattering induced by the motogens LPA and HGF, and whether these motogenic stimuli coordinate upregulation and/or secretion of Ln-5.
In Aim 2, we will test the hypothesis that a Ln- 5/?6?4/hemidesmosome axis regulates cell-cell adhesion and tumor progression. Engagement of ?6?4 with Ln-5 antagonizes ?3?1-mediated migration and enhances cell-cell adhesion via ErbB2. This suggests negative regulation of tumor progression by ?6?4, vis-?-vis cancer poor prognosis associated with ErbB2 gene amplification. Recent in vivo data, from ourselves and others, suggest a tumor suppressive role for secreted Ln-5 heterotrimers. Our hypothesis is based on the premise that these apparently contradictory data reflect the status of cancer cell anchoring to Ln-5 via hemidesmosomes (HD), regulated by ?6?4 in cells switching from migratory to stationary and vice versa. To test this hypothesis, we will investigate the role of the ?6?4/HD axis in cell-cell adhesion and ErbB2 localization in cell lines genetically manipulated to express normal or oncogenic ErbB2, and siRNA knocked-down of HD components. Readout assays include cell-cell adhesion measurements in vitro and xenogeneic tumor models in vivo.
In Aim 3, we will test the hypothesis that the ?2DIII domain of Ln-5 promotes tumor progression through EGFR. Expression of monomeric Ln-5 ?2 chain is consistently associated with invasion by many reports and our own preliminary microarray analyses. The ?2DIII proteolytic fragment binds EGFR and our preliminary data indicate it upregulates resistance to apoptosis and tumorigenesis in vivo. We will test the ?2DIII effects on in vitro morphology and survival and in vivo tumor growth and invasion, by siRNA knockdown and rescue with ?2 chain or ?2DIII fragment variants, and will assess its binding to additional ErbB family members. In summary, the 3 aims will test validity and limitations of an integrated view of the opposing effects on tumor progression by secreted Ln-5 heterotrimers (negative) and monomeric ?2 (positive). Understanding these mechanisms of cancer invasion may point to new molecular targets for controlling cancer invasion and metastasis, the major cause of mortality in cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Woodhouse, Elizabeth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Georgescu, Walter; Wikswo, John P; Quaranta, Vito (2012) CellAnimation: an open source MATLAB framework for microscopy assays. Bioinformatics 28:138-9
Tripathi, Manisha; Potdar, Alka A; Yamashita, Hironobu et al. (2011) Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells. Prostate 71:184-96
Liu, Shanshan; Yamashita, Hironobu; Weidow, Brandy et al. (2010) Laminin-332-beta1 integrin interactions negatively regulate invadopodia. J Cell Physiol 223:134-42
Yamashita, Hironobu; Tripathi, Manisha; Harris, Mark P et al. (2010) The role of a recombinant fragment of laminin-332 in integrin alpha3beta1-dependent cell binding, spreading and migration. Biomaterials 31:5110-21
Quaranta, Vito; Tyson, Darren R; Garbett, Shawn P et al. (2009) Trait variability of cancer cells quantified by high-content automated microscopy of single cells. Methods Enzymol 467:23-57
Guess, Cherise M; Quaranta, Vito (2009) Defining the role of laminin-332 in carcinoma. Matrix Biol 28:445-55
Guess, Cherise M; Lafleur, Bonnie J; Weidow, Brandy L et al. (2009) A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancer. Cancer Epidemiol Biomarkers Prev 18:1584-90
Harris, Mark P; Kim, Eric; Weidow, Brandy et al. (2008) Migration of isogenic cell lines quantified by dynamic multivariate analysis of single-cell motility. Cell Adh Migr 2:127-36
Tripathi, Manisha; Nandana, Srinivas; Yamashita, Hironobu et al. (2008) Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. J Biol Chem 283:30576-84
Kam, Yoonseok; Guess, Cherise; Estrada, Lourdes et al. (2008) A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro. BMC Cancer 8:198

Showing the most recent 10 out of 41 publications